A groundbreaking test developed in British Columbia can now determine which parent passed on a gene associated with an elevated risk of cancer. This innovation, reported by Shannon Paterson, offers new possibilities for personalized medicine and targeted prevention strategies.
How the test works
The test analyzes specific genetic markers to trace the origin of a mutated gene linked to cancer susceptibility. By identifying whether the gene came from the mother or father, doctors can better assess a patient's risk and recommend tailored screening or preventive measures.
This advancement is particularly significant for individuals with a family history of cancer, as it provides clarity on inheritance patterns. The test is expected to improve risk assessment for cancers such as breast, ovarian, and colorectal, where parent-of-origin effects can influence disease likelihood.
Implications for patients
For patients, knowing which parent contributed the risky gene can guide decisions about lifestyle changes, frequency of screenings, and even preventive surgeries. It also helps in counseling other family members who may be at risk.
Researchers in B.C. are optimistic that this test will become a standard part of genetic counseling. The development underscores the province's leadership in precision medicine and genetic research.
Future directions
The team behind the test is now working to expand its application to other cancer types and to integrate it into routine clinical practice. They hope that this tool will empower patients and healthcare providers with more precise information for cancer prevention.
As genetic testing becomes more accessible, such innovations could transform how we approach hereditary cancer risk, moving from a one-size-fits-all model to a more individualized strategy.
